These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11049040)

  • 21. A historical perspective on oxaliplatin: rethinking the role of platinum compounds and learning from near misses.
    Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):1-3. PubMed ID: 9609102
    [No Abstract]   [Full Text] [Related]  

  • 22. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.
    Schrag D; Weiser M; Schattner M; Shia J; Akhurst T
    J Clin Oncol; 2005 Mar; 23(9):1799-802. PubMed ID: 15774773
    [No Abstract]   [Full Text] [Related]  

  • 23. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy.
    Lissoni P; Brivio F; Fumagalli L; Di Fede G; Brera G
    In Vivo; 2005; 19(6):1077-80. PubMed ID: 16277025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New drug approved for colorectal cancer.
    FDA Consum; 2002; 36(5):2. PubMed ID: 12412532
    [No Abstract]   [Full Text] [Related]  

  • 26. [January 2004: a month of success with oxaliplatin and hope for patients with colorectal cancer].
    Tumori; 2004; 90(1):suppl 28-30. PubMed ID: 15143997
    [No Abstract]   [Full Text] [Related]  

  • 27. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
    Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
    [No Abstract]   [Full Text] [Related]  

  • 28. [ASCO 2005: Progression with oxaliplatin in the treatment of colorectal neoplasms].
    Longo F; Mansueto G
    Tumori; 2005; 91(3):suppl 1-12. PubMed ID: 16206661
    [No Abstract]   [Full Text] [Related]  

  • 29. [New chemotherapies for colorectal cancer treatment].
    Louvet C
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B51-6. PubMed ID: 11449145
    [No Abstract]   [Full Text] [Related]  

  • 30. Skin testing and hypersensitivity reactions to oxaliplatin.
    Garufi C; Cristaudo A; Vanni B; Bria E; Aschelter AM; Santucci B; Terzoli E
    Ann Oncol; 2003 Mar; 14(3):497-8. PubMed ID: 12598359
    [No Abstract]   [Full Text] [Related]  

  • 31. Splenomegaly during oxaliplatin-based chemotherapy for colorectal carcinoma.
    Jung EJ; Ryu CG; Kim G; Kim SR; Park HS; Kim YJ; Hwang DY
    Anticancer Res; 2012 Aug; 32(8):3357-62. PubMed ID: 22843915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxaliplatin.
    Graham J; Mushin M; Kirkpatrick P
    Nat Rev Drug Discov; 2004 Jan; 3(1):11-2. PubMed ID: 14756144
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA evaluating oxaliplatin for advanced colorectal cancer treatment.
    Baldwin J
    J Natl Cancer Inst; 2002 Aug; 94(16):1191-3. PubMed ID: 12189219
    [No Abstract]   [Full Text] [Related]  

  • 34. Dysphonia as an unusual toxic event of oxaliplatin-based chemotherapy.
    Berretta M; Taibi R; Bearz A; La Mura N; Berretta S; Tirelli U; Frustaci S
    J Chemother; 2004 Dec; 16(6):595-8. PubMed ID: 15700853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New treatments for colon cancer.
    Slevin M; Payne S
    BMJ; 2004 Jul; 329(7458):124-6. PubMed ID: 15258046
    [No Abstract]   [Full Text] [Related]  

  • 36. Oxaliplatin in practice.
    Misset JL
    Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):4-7. PubMed ID: 9647612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of advanced colorectal cancer.
    O'Dwyer PJ; Stevenson JP
    Cancer Treat Res; 1998; 98():111-52. PubMed ID: 10326667
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatocellular carcinoma and nodular regenerative hyperplasia after chemotherapy for metastatic colorectal carcinoma.
    Calderaro J; Azoulay D; Zafrani ES
    Hepatology; 2014 Oct; 60(4):1440-1. PubMed ID: 24604623
    [No Abstract]   [Full Text] [Related]  

  • 40. A review of oxaliplatin and its clinical use in colorectal cancer.
    Grothey A; Goldberg RM
    Expert Opin Pharmacother; 2004 Oct; 5(10):2159-70. PubMed ID: 15461551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.